Mural Oncology Plc
(MURA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -128,514 | -207,447 | -189,807 |
| Depreciation Amortization | 3,512 | 2,567 | 1,540 |
| Accounts receivable | 5,497 | N/A | N/A |
| Other Working Capital | -6,046 | -13,478 | 7,748 |
| Other Operating Activity | -2,994 | 24,109 | 11,931 |
| Operating Cash Flow | $-128,545 | $-194,249 | $-168,588 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -25,305 | N/A | N/A |
| PPE Investments | -25 | -3,452 | -5,511 |
| Investing Cash Flow | $-25,330 | $-3,452 | $-5,511 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 196 | N/A | N/A |
| Other Financing Activity | 0 | 468,811 | 174,099 |
| Financing Cash Flow | $196 | $468,811 | $174,099 |
| Beginning Cash Position | 271,110 | N/A | N/A |
| End Cash Position | 117,431 | 271,110 | N/A |
| Net Cash Flow | $-153,679 | $271,110 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -128,545 | -194,249 | -168,588 |
| Capital Expenditure | -92 | -3,452 | -5,511 |
| Free Cash Flow | -128,637 | -197,701 | -174,099 |